Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

NCT02143999 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02143999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
June 27, 2014
Completion date
December 30, 2016
Enrollment
403 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma